Through the 90-day period concluding February 10, 2026, Johnson & Johnson's top three insider stakeholders include Director Alex Gorsky (766.58K shares), Ceo And Chairman Of The Board Joaquin Duato (306.82K shares), Evp And Wwc. Innovative Medicine Jennifer L Taubert (178.01K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Alex Gorsky | 766,584 | 18 Jan, 2023 | |
| Joaquin Duato | Ceo And Chairman Of The Board | 306,819 | 25 Aug, 2025 |
| Jennifer L Taubert | Evp And Wwc. Innovative Medicine | 178,013 | 05 Sep, 2025 |
| Michael H Ullmann | Exec Vp And General Counsel | 158,835 | 17 Feb, 2022 |
| Peter Fasolo | Exec Vp And Chief Hr Officer | 112,076 | 15 Feb, 2024 |
| Kathryn E Wengel | Evp And Chief To And Risk Officer | 105,956 | 09 Feb, 2026 |
| Thibaut Mongon | Exec Vp And Ww Chair And Cons Health | 65,915 | 15 Feb, 2023 |
| Ashley Mcevoy | Evp And Ww Chair And Medtech | 52,038 | 25 Aug, 2023 |
| Mathai Mammen | Evp And Pharm And R&D | 41,934 | 17 Feb, 2022 |
| William Hait | Nan | 38,647 | 15 Feb, 2024 |
| Vanessa Broadhurst | Evp And Global Corp Affairs | 23,594 | 18 Feb, 2025 |
| Timothy Schmid | Evp And Ww Chair And Medtech | 22,125 | 10 Feb, 2026 |
| Robert J Decker | Vp Corporate Controller | 21,001 | 26 Feb, 2025 |
| James D. Swanson | Evp And Cio | 18,850 | 18 Feb, 2025 |
| Kristen Mulholland | Evp And Chief Hr Officer | 16,409 | 09 Feb, 2026 |
| Elizabeth Forminard | Evp And Chief Legal Officer | 15,548 | 06 Feb, 2026 |
| Joseph J Wolk | Exec Vp And Cfo | 14,000 | 18 Aug, 2025 |
| John C Reed | Evp And Innovative Medicine And R&D | 10,658 | 20 Oct, 2025 |
| John G Morikis | 1,849 | 01 Dec, 2025 | |
| Mark A Weinberger | 1,000 | 12 Dec, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 06 Feb, 2026 | Kathryn E Wengel | Common Stock | D | 27,270 | $239.99 | 105,956 | D | F |
| 06 Feb, 2026 | Kathryn E Wengel | Common Stock | A | 38,945 | $101.87 | 133,226 | D | M |
| 06 Feb, 2026 | Timothy Schmid | Common Stock | A | 15,571 | $101.87 | 32,460 | D | M |
| 06 Feb, 2026 | Timothy Schmid | Common Stock | D | 10,335 | $239.99 | 22,125 | D | F |
| 06 Feb, 2026 | Kristen Mulholland | Common Stock | A | 5,625 | $101.87 | 19,744 | D | M |
| 06 Feb, 2026 | Kristen Mulholland | Common Stock | D | 3,335 | $239.99 | 16,409 | D | F |
| 05 Feb, 2026 | Elizabeth Forminard | Common Stock | D | 6,226 | $237.90 | 15,548 | D | F |
| 05 Feb, 2026 | Elizabeth Forminard | Common Stock | A | 8,921 | $129.51 | 21,774 | D | M |
| 26 Jan, 2026 | Joaquin Duato | Common Stock | D | 48,782 | $221.48 | 30,852 | I | S |
| 26 Jan, 2026 | Joaquin Duato | Common Stock | D | 51,218 | $220.99 | 79,634 | I | S |
| 26 Nov, 2025 | John G Morikis | Common Stock | A | 1,250 | $206.15 | 1,849 | D | P |
| 26 Nov, 2025 | John G Morikis | - | - | 1,849 | D | |||
| 17 Oct, 2025 | John C Reed | - | - | 10,658 | D | |||
| 17 Oct, 2025 | John C Reed | Common Stock | A | 21,721 | $157.92 | 32,379 | D | M |
| 17 Oct, 2025 | John C Reed | Common Stock | D | 21,721 | $192.71 | 10,658 | D | S |
| 17 Oct, 2025 | John C Reed | - | - | 32,379 | D | |||
| 04 Sep, 2025 | Jennifer L Taubert | Common Stock | A | 56,471 | $101.87 | 234,484 | D | M |
| 04 Sep, 2025 | Jennifer L Taubert | - | - | 234,484 | D | |||
| 04 Sep, 2025 | Jennifer L Taubert | Common Stock | D | 56,471 | $177.81 | 178,013 | D | S |
| 04 Sep, 2025 | Jennifer L Taubert | - | - | 178,013 | D |